Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects

American Journal of Cardiology

Volumn 86, Issue 10, 2000, Pages 1117-1122

  Festa, Andreas ^a   D'Agostino Jr , Ralph ^b   Rautaharju, Pentti ^b   Mykkänen, Leena ^a   Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; ETHNIC DIFFERENCE; FEMALE; GLUCOSE TOLERANCE TEST; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QT INTERVAL; SEX DIFFERENCE;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; LINEAR MODELS; LONG QT SYNDROME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 0034670113     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01170-X     Document Type: Article

References (29)

1. QT-interval prolongation predicts cardiovascular mortality in an apparently healthy population
2. Association between QT interval and coronary heart disease in middle-aged and elderly men; the Zutphen study
3. Prognostic value of prolonged ventricular repolarization following myocardial infarction; the BHAT experience
4. Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study Experience)
5. Correlates of QT prolongation in older adults (the Cardiovascular Health Study)
6. Obesity, adiposity, and lengthening of the QT interval; improvement after weight loss
7. QT interval as a cardiac risk factor in a middle aged population
8. Prolonged QT period in diabetic autonomic neuropathy; a possible role in sudden cardiac death?
9. QT(c) duration is associated with levels of insulin and glucose tolerance. The Zutphen Elderly Study
10. Effect of obesity and regional adiposity on the QTc interval in women
11. The Insulin Resistance Atherosclerosis Study (IRAS); objectives, design and recruitment results
12. The long QT syndrome; ion channel diseases of the heart
13. Assessment of insulin sensitivity in vivo
14. MINMOD; a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
15. Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects
16. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model; suitability for use in population studies
17. Coated charcoal immunoassay of insulin
18. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulin
19. The measurement of fibrinogen in population-based research; studies on instrumentation and methodology
20. Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies
21. Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays
22. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression
23. Utility of new electrocardiographic models for left ventricular mass in older adults
24. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
25. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
26. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
27. Role of oxidative stress in development of complications in diabetes